Global Anti-Diabetic Drugs Market Growth (Status and Outlook) 2023-2029

February 2023 | 87 pages | ID: GA950AC45ED1EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for diabetes have become the focal point of attention due to the burgeoning diabetic population size, with diabetes affecting middle age groups and children across all income groups globally.

LPI (LP Information)' newest research report, the “Anti-Diabetic Drugs Industry Forecast” looks at past sales and reviews total world Anti-Diabetic Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-Diabetic Drugs sales for 2023 through 2029. With Anti-Diabetic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Diabetic Drugs industry.

This Insight Report provides a comprehensive analysis of the global Anti-Diabetic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Diabetic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-Diabetic Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Diabetic Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Diabetic Drugs.

The global Anti-Diabetic Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

Some of the major drivers and opportunities for growth of this market include drug combinations of several agents such as sitagliptin and metformin and other drug combinations that are in different stages of clinical and pipeline development. Increase in the prevalence of diabetes and new product launches by major pharmaceutical companies re some of the key drivers for growth in this market. In 2015, Boehringer Ingelheim GmbH launched two new drugs (Synjardy & Glyxambi)for treatment of diabetes mellitus type II.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Diabetic Drugs market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Biguanides
• Sulfonylureas
• Meglitinides
• Thiazolidinediones
• Dipeptidyl Peptidase IV Inhibitors
• ?-Glucosidase Inhibitors

Segmentation by application

• Type I Diabetes
• Type II Diabetes
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Astra Zeneca
• Boehringer Ingelheim
• Eli Lilly
• Johnson & Johnson
• Merck
• Novartis
• Novo Nordisk
• Sanofi
• Teva Pharmaceutical Industries

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Anti-Diabetic Drugs Market Size 2018-2029
  2.1.2 Anti-Diabetic Drugs Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Anti-Diabetic Drugs Segment by Type
  2.2.1 Biguanides
  2.2.2 Sulfonylureas
  2.2.3 Meglitinides
  2.2.4 Thiazolidinediones
  2.2.5 Dipeptidyl Peptidase IV Inhibitors
  2.2.6 ?-Glucosidase Inhibitors
2.3 Anti-Diabetic Drugs Market Size by Type
  2.3.1 Anti-Diabetic Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Anti-Diabetic Drugs Market Size Market Share by Type (2018-2023)
2.4 Anti-Diabetic Drugs Segment by Application
  2.4.1 Type I Diabetes
  2.4.2 Type II Diabetes
  2.4.3 Others
2.5 Anti-Diabetic Drugs Market Size by Application
  2.5.1 Anti-Diabetic Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Anti-Diabetic Drugs Market Size Market Share by Application (2018-2023)

3 ANTI-DIABETIC DRUGS MARKET SIZE BY PLAYER

3.1 Anti-Diabetic Drugs Market Size Market Share by Players
  3.1.1 Global Anti-Diabetic Drugs Revenue by Players (2018-2023)
  3.1.2 Global Anti-Diabetic Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Anti-Diabetic Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ANTI-DIABETIC DRUGS BY REGIONS

4.1 Anti-Diabetic Drugs Market Size by Regions (2018-2023)
4.2 Americas Anti-Diabetic Drugs Market Size Growth (2018-2023)
4.3 APAC Anti-Diabetic Drugs Market Size Growth (2018-2023)
4.4 Europe Anti-Diabetic Drugs Market Size Growth (2018-2023)
4.5 Middle East & Africa Anti-Diabetic Drugs Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Anti-Diabetic Drugs Market Size by Country (2018-2023)
5.2 Americas Anti-Diabetic Drugs Market Size by Type (2018-2023)
5.3 Americas Anti-Diabetic Drugs Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Anti-Diabetic Drugs Market Size by Region (2018-2023)
6.2 APAC Anti-Diabetic Drugs Market Size by Type (2018-2023)
6.3 APAC Anti-Diabetic Drugs Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Anti-Diabetic Drugs by Country (2018-2023)
7.2 Europe Anti-Diabetic Drugs Market Size by Type (2018-2023)
7.3 Europe Anti-Diabetic Drugs Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Anti-Diabetic Drugs by Region (2018-2023)
8.2 Middle East & Africa Anti-Diabetic Drugs Market Size by Type (2018-2023)
8.3 Middle East & Africa Anti-Diabetic Drugs Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ANTI-DIABETIC DRUGS MARKET FORECAST

10.1 Global Anti-Diabetic Drugs Forecast by Regions (2024-2029)
  10.1.1 Global Anti-Diabetic Drugs Forecast by Regions (2024-2029)
  10.1.2 Americas Anti-Diabetic Drugs Forecast
  10.1.3 APAC Anti-Diabetic Drugs Forecast
  10.1.4 Europe Anti-Diabetic Drugs Forecast
  10.1.5 Middle East & Africa Anti-Diabetic Drugs Forecast
10.2 Americas Anti-Diabetic Drugs Forecast by Country (2024-2029)
  10.2.1 United States Anti-Diabetic Drugs Market Forecast
  10.2.2 Canada Anti-Diabetic Drugs Market Forecast
  10.2.3 Mexico Anti-Diabetic Drugs Market Forecast
  10.2.4 Brazil Anti-Diabetic Drugs Market Forecast
10.3 APAC Anti-Diabetic Drugs Forecast by Region (2024-2029)
  10.3.1 China Anti-Diabetic Drugs Market Forecast
  10.3.2 Japan Anti-Diabetic Drugs Market Forecast
  10.3.3 Korea Anti-Diabetic Drugs Market Forecast
  10.3.4 Southeast Asia Anti-Diabetic Drugs Market Forecast
  10.3.5 India Anti-Diabetic Drugs Market Forecast
  10.3.6 Australia Anti-Diabetic Drugs Market Forecast
10.4 Europe Anti-Diabetic Drugs Forecast by Country (2024-2029)
  10.4.1 Germany Anti-Diabetic Drugs Market Forecast
  10.4.2 France Anti-Diabetic Drugs Market Forecast
  10.4.3 UK Anti-Diabetic Drugs Market Forecast
  10.4.4 Italy Anti-Diabetic Drugs Market Forecast
  10.4.5 Russia Anti-Diabetic Drugs Market Forecast
10.5 Middle East & Africa Anti-Diabetic Drugs Forecast by Region (2024-2029)
  10.5.1 Egypt Anti-Diabetic Drugs Market Forecast
  10.5.2 South Africa Anti-Diabetic Drugs Market Forecast
  10.5.3 Israel Anti-Diabetic Drugs Market Forecast
  10.5.4 Turkey Anti-Diabetic Drugs Market Forecast
  10.5.5 GCC Countries Anti-Diabetic Drugs Market Forecast
10.6 Global Anti-Diabetic Drugs Forecast by Type (2024-2029)
10.7 Global Anti-Diabetic Drugs Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Astra Zeneca
  11.1.1 Astra Zeneca Company Information
  11.1.2 Astra Zeneca Anti-Diabetic Drugs Product Offered
  11.1.3 Astra Zeneca Anti-Diabetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Astra Zeneca Main Business Overview
  11.1.5 Astra Zeneca Latest Developments
11.2 Boehringer Ingelheim
  11.2.1 Boehringer Ingelheim Company Information
  11.2.2 Boehringer Ingelheim Anti-Diabetic Drugs Product Offered
  11.2.3 Boehringer Ingelheim Anti-Diabetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Boehringer Ingelheim Main Business Overview
  11.2.5 Boehringer Ingelheim Latest Developments
11.3 Eli Lilly
  11.3.1 Eli Lilly Company Information
  11.3.2 Eli Lilly Anti-Diabetic Drugs Product Offered
  11.3.3 Eli Lilly Anti-Diabetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Eli Lilly Main Business Overview
  11.3.5 Eli Lilly Latest Developments
11.4 Johnson & Johnson
  11.4.1 Johnson & Johnson Company Information
  11.4.2 Johnson & Johnson Anti-Diabetic Drugs Product Offered
  11.4.3 Johnson & Johnson Anti-Diabetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Johnson & Johnson Main Business Overview
  11.4.5 Johnson & Johnson Latest Developments
11.5 Merck
  11.5.1 Merck Company Information
  11.5.2 Merck Anti-Diabetic Drugs Product Offered
  11.5.3 Merck Anti-Diabetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Merck Main Business Overview
  11.5.5 Merck Latest Developments
11.6 Novartis
  11.6.1 Novartis Company Information
  11.6.2 Novartis Anti-Diabetic Drugs Product Offered
  11.6.3 Novartis Anti-Diabetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Novartis Main Business Overview
  11.6.5 Novartis Latest Developments
11.7 Novo Nordisk
  11.7.1 Novo Nordisk Company Information
  11.7.2 Novo Nordisk Anti-Diabetic Drugs Product Offered
  11.7.3 Novo Nordisk Anti-Diabetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Novo Nordisk Main Business Overview
  11.7.5 Novo Nordisk Latest Developments
11.8 Sanofi
  11.8.1 Sanofi Company Information
  11.8.2 Sanofi Anti-Diabetic Drugs Product Offered
  11.8.3 Sanofi Anti-Diabetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Sanofi Main Business Overview
  11.8.5 Sanofi Latest Developments
11.9 Teva Pharmaceutical Industries
  11.9.1 Teva Pharmaceutical Industries Company Information
  11.9.2 Teva Pharmaceutical Industries Anti-Diabetic Drugs Product Offered
  11.9.3 Teva Pharmaceutical Industries Anti-Diabetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Teva Pharmaceutical Industries Main Business Overview
  11.9.5 Teva Pharmaceutical Industries Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Anti-Diabetic Drugs Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Biguanides
Table 3. Major Players of Sulfonylureas
Table 4. Major Players of Meglitinides
Table 5. Major Players of Thiazolidinediones
Table 6. Major Players of Dipeptidyl Peptidase IV Inhibitors
Table 7. Major Players of ?-Glucosidase Inhibitors
Table 8. Anti-Diabetic Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Anti-Diabetic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 10. Global Anti-Diabetic Drugs Market Size Market Share by Type (2018-2023)
Table 11. Anti-Diabetic Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 12. Global Anti-Diabetic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 13. Global Anti-Diabetic Drugs Market Size Market Share by Application (2018-2023)
Table 14. Global Anti-Diabetic Drugs Revenue by Players (2018-2023) & ($ Millions)
Table 15. Global Anti-Diabetic Drugs Revenue Market Share by Player (2018-2023)
Table 16. Anti-Diabetic Drugs Key Players Head office and Products Offered
Table 17. Anti-Diabetic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Anti-Diabetic Drugs Market Size by Regions 2018-2023 & ($ Millions)
Table 21. Global Anti-Diabetic Drugs Market Size Market Share by Regions (2018-2023)
Table 22. Global Anti-Diabetic Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 23. Global Anti-Diabetic Drugs Revenue Market Share by Country/Region (2018-2023)
Table 24. Americas Anti-Diabetic Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 25. Americas Anti-Diabetic Drugs Market Size Market Share by Country (2018-2023)
Table 26. Americas Anti-Diabetic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 27. Americas Anti-Diabetic Drugs Market Size Market Share by Type (2018-2023)
Table 28. Americas Anti-Diabetic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 29. Americas Anti-Diabetic Drugs Market Size Market Share by Application (2018-2023)
Table 30. APAC Anti-Diabetic Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 31. APAC Anti-Diabetic Drugs Market Size Market Share by Region (2018-2023)
Table 32. APAC Anti-Diabetic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 33. APAC Anti-Diabetic Drugs Market Size Market Share by Type (2018-2023)
Table 34. APAC Anti-Diabetic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 35. APAC Anti-Diabetic Drugs Market Size Market Share by Application (2018-2023)
Table 36. Europe Anti-Diabetic Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 37. Europe Anti-Diabetic Drugs Market Size Market Share by Country (2018-2023)
Table 38. Europe Anti-Diabetic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 39. Europe Anti-Diabetic Drugs Market Size Market Share by Type (2018-2023)
Table 40. Europe Anti-Diabetic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 41. Europe Anti-Diabetic Drugs Market Size Market Share by Application (2018-2023)
Table 42. Middle East & Africa Anti-Diabetic Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Anti-Diabetic Drugs Market Size Market Share by Region (2018-2023)
Table 44. Middle East & Africa Anti-Diabetic Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Anti-Diabetic Drugs Market Size Market Share by Type (2018-2023)
Table 46. Middle East & Africa Anti-Diabetic Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 47. Middle East & Africa Anti-Diabetic Drugs Market Size Market Share by Application (2018-2023)
Table 48. Key Market Drivers & Growth Opportunities of Anti-Diabetic Drugs
Table 49. Key Market Challenges & Risks of Anti-Diabetic Drugs
Table 50. Key Industry Trends of Anti-Diabetic Drugs
Table 51. Global Anti-Diabetic Drugs Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 52. Global Anti-Diabetic Drugs Market Size Market Share Forecast by Regions (2024-2029)
Table 53. Global Anti-Diabetic Drugs Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 54. Global Anti-Diabetic Drugs Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 55. Astra Zeneca Details, Company Type, Anti-Diabetic Drugs Area Served and Its Competitors
Table 56. Astra Zeneca Anti-Diabetic Drugs Product Offered
Table 57. Astra Zeneca Anti-Diabetic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 58. Astra Zeneca Main Business
Table 59. Astra Zeneca Latest Developments
Table 60. Boehringer Ingelheim Details, Company Type, Anti-Diabetic Drugs Area Served and Its Competitors
Table 61. Boehringer Ingelheim Anti-Diabetic Drugs Product Offered
Table 62. Boehringer Ingelheim Main Business
Table 63. Boehringer Ingelheim Anti-Diabetic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 64. Boehringer Ingelheim Latest Developments
Table 65. Eli Lilly Details, Company Type, Anti-Diabetic Drugs Area Served and Its Competitors
Table 66. Eli Lilly Anti-Diabetic Drugs Product Offered
Table 67. Eli Lilly Main Business
Table 68. Eli Lilly Anti-Diabetic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 69. Eli Lilly Latest Developments
Table 70. Johnson & Johnson Details, Company Type, Anti-Diabetic Drugs Area Served and Its Competitors
Table 71. Johnson & Johnson Anti-Diabetic Drugs Product Offered
Table 72. Johnson & Johnson Main Business
Table 73. Johnson & Johnson Anti-Diabetic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 74. Johnson & Johnson Latest Developments
Table 75. Merck Details, Company Type, Anti-Diabetic Drugs Area Served and Its Competitors
Table 76. Merck Anti-Diabetic Drugs Product Offered
Table 77. Merck Main Business
Table 78. Merck Anti-Diabetic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 79. Merck Latest Developments
Table 80. Novartis Details, Company Type, Anti-Diabetic Drugs Area Served and Its Competitors
Table 81. Novartis Anti-Diabetic Drugs Product Offered
Table 82. Novartis Main Business
Table 83. Novartis Anti-Diabetic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 84. Novartis Latest Developments
Table 85. Novo Nordisk Details, Company Type, Anti-Diabetic Drugs Area Served and Its Competitors
Table 86. Novo Nordisk Anti-Diabetic Drugs Product Offered
Table 87. Novo Nordisk Main Business
Table 88. Novo Nordisk Anti-Diabetic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 89. Novo Nordisk Latest Developments
Table 90. Sanofi Details, Company Type, Anti-Diabetic Drugs Area Served and Its Competitors
Table 91. Sanofi Anti-Diabetic Drugs Product Offered
Table 92. Sanofi Main Business
Table 93. Sanofi Anti-Diabetic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 94. Sanofi Latest Developments
Table 95. Teva Pharmaceutical Industries Details, Company Type, Anti-Diabetic Drugs Area Served and Its Competitors
Table 96. Teva Pharmaceutical Industries Anti-Diabetic Drugs Product Offered
Table 97. Teva Pharmaceutical Industries Main Business
Table 98. Teva Pharmaceutical Industries Anti-Diabetic Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 99. Teva Pharmaceutical Industries Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Anti-Diabetic Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anti-Diabetic Drugs Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Anti-Diabetic Drugs Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Anti-Diabetic Drugs Sales Market Share by Country/Region (2022)
Figure 8. Anti-Diabetic Drugs Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Anti-Diabetic Drugs Market Size Market Share by Type in 2022
Figure 10. Anti-Diabetic Drugs in Type I Diabetes
Figure 11. Global Anti-Diabetic Drugs Market: Type I Diabetes (2018-2023) & ($ Millions)
Figure 12. Anti-Diabetic Drugs in Type II Diabetes
Figure 13. Global Anti-Diabetic Drugs Market: Type II Diabetes (2018-2023) & ($ Millions)
Figure 14. Anti-Diabetic Drugs in Others
Figure 15. Global Anti-Diabetic Drugs Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Anti-Diabetic Drugs Market Size Market Share by Application in 2022
Figure 17. Global Anti-Diabetic Drugs Revenue Market Share by Player in 2022
Figure 18. Global Anti-Diabetic Drugs Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Anti-Diabetic Drugs Market Size 2018-2023 ($ Millions)
Figure 20. APAC Anti-Diabetic Drugs Market Size 2018-2023 ($ Millions)
Figure 21. Europe Anti-Diabetic Drugs Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Anti-Diabetic Drugs Market Size 2018-2023 ($ Millions)
Figure 23. Americas Anti-Diabetic Drugs Value Market Share by Country in 2022
Figure 24. United States Anti-Diabetic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Anti-Diabetic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Anti-Diabetic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Anti-Diabetic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Anti-Diabetic Drugs Market Size Market Share by Region in 2022
Figure 29. APAC Anti-Diabetic Drugs Market Size Market Share by Type in 2022
Figure 30. APAC Anti-Diabetic Drugs Market Size Market Share by Application in 2022
Figure 31. China Anti-Diabetic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Anti-Diabetic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Anti-Diabetic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Anti-Diabetic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Anti-Diabetic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Anti-Diabetic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Anti-Diabetic Drugs Market Size Market Share by Country in 2022
Figure 38. Europe Anti-Diabetic Drugs Market Size Market Share by Type (2018-2023)
Figure 39. Europe Anti-Diabetic Drugs Market Size Market Share by Application (2018-2023)
Figure 40. Germany Anti-Diabetic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Anti-Diabetic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Anti-Diabetic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Anti-Diabetic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Anti-Diabetic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Anti-Diabetic Drugs Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Anti-Diabetic Drugs Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Anti-Diabetic Drugs Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Anti-Diabetic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Anti-Diabetic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Anti-Diabetic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Anti-Diabetic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Anti-Diabetic Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 54. APAC Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 55. Europe Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 57. United States Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 58. Canada Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 61. China Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 62. Japan Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 63. Korea Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 65. India Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 66. Australia Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 67. Germany Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 68. France Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 69. UK Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 70. Italy Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 71. Russia Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 72. Spain Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 75. Israel Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Anti-Diabetic Drugs Market Size 2024-2029 ($ Millions)
Figure 78. Global Anti-Diabetic Drugs Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Anti-Diabetic Drugs Market Size Market Share Forecast by Application (2024-2029)